Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures-Reference-Cited by-同舟云学术

Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures

Published:2017-07-11 Issue:9 Volume:24 Page:1099-1107
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Khurana V.¹^ORCID,Sharma H.¹,Afroz N.¹,Callan A.²,Medin J.³

Affiliation:

1. Product Lifecycle Services - NBS; Novartis Healthcare Private Limited; Hyderabad India

2. Product Lifecycle Services - NBS; Novartis Global Service Center; Dublin Ireland

3. Global Patient Access; Novartis Pharma AG; Basel Switzerland

Funder

Novartis Pharma

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.13339/fullpdf

Reference47 articles.

1. Burden of a multiple sclerosis relapse: the patient's perspective;Oleen-Burkey;Patient,2012

2. Kobelt G Kasteng F Access to innovative treatments in multiple sclerosis in Europe: A report prepared for the European Federation of Pharmaceutical Industry Associations (EFPIA) 2009 www.comparatorreports.se/Access%20to%20MS%20treatments%20-%20October%202009.pdf

3. The routine use of patient reported outcome measures in healthcare settings;Dawson;BMJ,2010

4. Patient reported outcome measures could help transform healthcare;Black;BMJ,2013

5. Food and Drug Administration Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims 2009 http://www.fda.gov/downloads/Drugs/.../Guidances/UCM193282.pdf

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic literature review of the measurement of patient-reported fatigue in studies of disease modifying therapies for multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-11

2. Cross-cultural adaptation and validation of the Arabic version of the Multiple Sclerosis Impact Scale-29;Disability and Rehabilitation;2024-05-13

3. Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis;Journal of Neurology;2024-04-16

4. Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy;Frontiers in Neurology;2024-04-04

5. Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the “power training in older multiple sclerosis patients (PoTOMS) randomized control trial;Contemporary Clinical Trials Communications;2024-04